Genotoxicity and safety pharmacology of the rVSVInd(GML)-mspSGtc vaccine against SARS-CoV-2 in Sprague-Dawley rats and Beagle dogs
Arch Toxicol. 2024 Apr 12. doi: 10.1007/s00204-024-03746-x. Online ahead of print.ABSTRACTThe emergence of coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) led to a pandemic, prompting rapid vaccine development. Although vaccines are effective, the occurrence of rare adverse events following vaccination highlights the necessity of determining whether the benefits outweigh the risks posed by the infection itself. The recombinant Vesicular Stomatitis Virus (rVSV) platform is a promising vector for vaccines against emerging viruses. However, limited studies have evaluated the genotoxicity and safety pharmacology of this viral vector vaccine, which is crucial to ensure the safety of vaccines developed using this platform. Hence, the present study aimed to assess the genotoxicity and safety pharmacology of the rVSVInd(GML)-mspSGtc COVID-19 vaccine using micronucleus and comet assays, as well as neurobehavioral, body temperature, respiratory, and cardiovascular assessments in Sprague-Dawley rats and beagle dogs. The intramuscular administration of rVSVInd(GML)-mspSGtc at doses up to 1.5 × 109 PFU/animal did not increase the number of bone marrow micronucleated polychromatic erythrocytes or cause liver DNA damage. Additionally, it had no significant impact on neurobehavioral functions in rats and showed marginal temporary changes in body temperature, respiratory rate, heart rate, and electrocardiogram parameters in rats and dogs,...
Source: Archives of Toxicology - Category: Toxicology Authors: Sang-Jin Park Heeseon Park Seng-Min Back Young Ju Lee Joung-Wook Seo Dabi Kim Jeong Hwa Lee Chaewon Kwak Kang-Hyun Han Hwa-Young Son Yong-Bum Kim Source Type: research
More News: Brain | Cardiology | Cardiovascular | Clinical Trials | Coronavirus | Covid Vaccine | COVID-19 | Drugs & Pharmacology | Electrocardiogram | Heart | Liver | Neurology | Pandemics | Respiratory Medicine | SARS | Study | Toxicology | Urology & Nephrology | Vaccines | Veterinary Vaccinations